News
Plus, news about Oruka Therapeutics, Centessa, Takeda, Innate Pharma and Liquidia: GSK’s mRNA flu vaccine succeeds against both strains in Phase 2: The pharma company ...
Senate Finance Committee Chair Ron Wyden (D-OR) is urging HHS to take a stronger stance on healthcare companies' cybersecurity practices as the healthcare system is still piecing together what ...
Merck and Kelun-Biotech revealed Phase 3 breast cancer data for the lead antibody-drug conjugate in their potentially $12 billion partnership. In a Phase 3 trial for locally recurrent or ...
April 29, 2024 05:53 PM EDT Updated 06:48 PM ...
To help meet the heightened demand for its injectable products, Eli Lilly is acquiring a facility from Nexus Pharmaceuticals, with production anticipated to start at the end of next year ...
March 11, 2024 04:54 AM EDT Updated March 12, 06:55 PM ...
House Republicans take issue with DOJ’s handling of Moderna’s Covid vaccine patents - Endpoints News
Reps. Kelly Armstrong (R-ND) and Ben Cline (R-VA) sent a letter last week to Attorney General Merrick Garland, asking why the Department of Justice is willing to incur potential patent ...
ARCH Venture Partners plans to raise $3 billion for its 13th fund, per a new SEC filing from this week. The Chicago-based venture capital firm has ...
Small molecule biotech Totus Medicines has closed a $66 million Series B to carry its PI3Kα inhibitor through Phase Ia and has named Nassim Usman as its new president and ...
Citius Pharmaceuticals plans to refile its experimental drug for a rare blood cancer in early 2024 following an FDA rejection in July. The drug … ...
A pair of late-stage biotechs submitted IPO plans last week as industry insiders gear up for what could be a handful of post-Labor Day public debut pitches. To repeat: That ...
The Biden administration’s new biomedical research agency is launching a $24.8 million project to develop mRNA platforms with the goal of using the technology to fight cancer and other life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results